AKT1 and colorectal carcinoma: Predictions for miRNAs sharing complementary binding sites in LBX2-AS1 and AKT1 uncovered miR-422a as a likely candidate (Fig. 6C), since miR-422a was previously established to target AKT1 in CRC [23].